• Adam Schneeweiss
  • Gotthard Schettler
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 72)


Lidocaine is the first drug of choice for acute suppression of malignant ventricular arrhythmias in all age groups, including elderly patients. Its use in elderly patients requires special caution, however.


Acute Myocardial Infarction Ventricular Fibrillation Premature Ventricular Beat Sinus Node Dysfunction Malignant Ventricular Arrhythmia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Liberman NA, Harris RS, Katz RI, Lipschutz HM, Dolgin M, Fisher VJ: The effects of lidocaine on the electrical and mechanical activity of the heart. Am J Cardiol 22:375, 1968.CrossRefGoogle Scholar
  2. 2.
    Kao FF, Jalar UH: The central action of lignocaine and its effect on cardiac output. Br J Pharmacol 14:522, 1959.Google Scholar
  3. 3.
    Dhingra RC, Deedwania PC, Cummings JM, Amat-Y-Leon F, Wu D, Denes P, Rosen KM: Electrophysiologic effects of lidocaine on sinus node and atrium in patients with a without sinoatrial dysfunction. Circulation 57:448, 1978.PubMedGoogle Scholar
  4. 4.
    Cranefield PF: The conduction of the cardiac impulse. Futura, Mount Kisco, NY, 1975, p 199.Google Scholar
  5. 5.
    Kermaler AL, Hayahawa H, Mandel WJ: Effect of lidocaine on the scalar orthogonal electrocardiogram. Am Heart J 84:366, 1972.CrossRefGoogle Scholar
  6. 6.
    Edvardsson N, et al: Electrophysiological effects of lidocaine in acute myocardial infarction with bifascicular block or complete A-V block. Cardiology 70:333, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Roos JC, Dunning AJ: Effects of lidocaine on impulse formation and conduction defects in man. Am Heart J 89:687, 1975.Google Scholar
  8. 8.
    Josephson ME, et al: Effects of lidocaine on refractory periods in man. Am Heart J 84:778, 1972.PubMedCrossRefGoogle Scholar
  9. 9.
    Rosen KM, et al: The effect of lidocaine on atrioventricular and intraventricular conduction in man. Am J Cardiol 25:1, 1970.PubMedCrossRefGoogle Scholar
  10. 10.
    Adamson AR, Spracklen FHN: Atrial flutter with block-contraindication to use of ligno-caine. Br Med J 2:223, 1968.PubMedCrossRefGoogle Scholar
  11. 11.
    Rosen KM, Barwolf C, Ehsani A, Rahimtoola SH: Effects of lidocaine and propranolol on the normal and anomalous pathways with pre-excitation. Am J Cardiol 30:801, 1972.PubMedCrossRefGoogle Scholar
  12. 12.
    Arnsdorf MF, Bigger JT Jr: Effect of lidocaine hydrochloride on membrane conductance in mammalian cardiac Purkinje fibers. J Clin Invest 51:2252, 1972.PubMedCrossRefGoogle Scholar
  13. 13.
    Liss JP, et al: Lidocaine in ventricular arrhythmia. Am Heart J 86:143, 1973.PubMedCrossRefGoogle Scholar
  14. 14.
    Hitchcock P, Keown KK: Management of cardiac arrhythmias during cardiac surgery. South Med J 52:702, 1959.PubMedCrossRefGoogle Scholar
  15. 15.
    Lidocaine Intervention Trial, Amsterdam. Koster RW, Dunning AJ: Pre-hospital prevention of ventricular fibrillation in acute myocardial infarction. AHA, 1983.Google Scholar
  16. 16.
    Likoff W: Cardiac arrhythmias complicating surgery. Am J Cardiol 3:427, 1959.PubMedCrossRefGoogle Scholar
  17. 17.
    Anderson JL, et al: Intravenous lorcainide versus lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized, crossover study. J Am Coll Cardiol 3:475, 1984.Google Scholar
  18. 18.
    De Silva RA, Hennekens CH, Lown B, Casscells W: Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials: Lancet 2:855, 1981.Google Scholar
  19. 19.
    Lie KI, Wellens HJ, Van Capelle FJ, Durred D: Lidocaine in the prevention of primary ventricular fibrillation: a double-blind, randomized study of 212 consecutive patients. N Engl J Med 291:1324, 1974.PubMedCrossRefGoogle Scholar
  20. 20.
    Lie KI: Lidocaine and prevention of ventricular fibrillation complicating acute myocardial infarction. Int J Cardiol 7:321, 1985.PubMedCrossRefGoogle Scholar
  21. 21.
    Julian DG, et al: Disturbances of rate, rhythm and conduction in acute myocardial infarction. Am J Med 37:915, 1964.PubMedCrossRefGoogle Scholar
  22. 22.
    Lie KI, et al: Treatment and prevention of primary ventricular fibrillation complicating acute myocardial infarction. Acta Cardiol [Suppl] 22:107, 1977.PubMedGoogle Scholar
  23. 23.
    Jewitt DE, Kishon Y, Thomas M: Lignocaine in the management of arrhythmias after acute myocardial infarction. Lancet 1:266, 1968.CrossRefGoogle Scholar
  24. 24.
    Dye CL: Atrial tachycardia in Wolff-Parkinson-White syndrome: conversion to normal sinus rhythm with lidocaine. Am J Cardiol 24:265, 1969.PubMedCrossRefGoogle Scholar
  25. 25.
    Akhtar M, Gilbert CJ, Shenasa M: Effect of lidocaine on atrioventricular response via the accessory pathway in patients with Wolff-Parkinson-White syndrome. Circulation 63:435, 1981.PubMedCrossRefGoogle Scholar
  26. 26.
    Bigger JT Jr, Mandel WJ: Effect of lidocaine on the electrophysiological properties of ventricular muscle and Purkinje fibers. J Clin Invest 49:63, 1970.PubMedCrossRefGoogle Scholar
  27. 27.
    Faria DB, Cheung WM, Ribeiro LGT, Maroko PR: Effects of lidocaine and droxicainide on myocardial necrosis: a comparative study. J Am Coll Cardiol 1:1447, 1983.PubMedCrossRefGoogle Scholar
  28. 28.
    Ryden L, Korsgren M: The effect of lignocaine on the stimulation threshold and conduction disturbances in patients treated with pacemaker. Cardiovasc Res 3:415, 1969.PubMedCrossRefGoogle Scholar
  29. 29.
    Aravindakshan V, et al: Effect of lidocaine on escape rate in patients with complete atrioventricular block. Am J Cardiol 40:177, 1977.PubMedCrossRefGoogle Scholar
  30. 30.
    Boyes RN, et al: Pharmacokinetics of lidocaine in man. Clin Pharmacol Ther 12:105, 1971.PubMedGoogle Scholar
  31. 31.
    Le Lorier J, et al: Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann Intern Med 87:700, 1977.Google Scholar
  32. 32.
    Ochs HR, et al: Reduction of lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med 303:373, 1980.PubMedCrossRefGoogle Scholar
  33. 33.
    Thomson PP, et al: Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med 78:499, 1973.PubMedGoogle Scholar
  34. 34.
    Nation RL, et al: Lignocaine kinetics in cardiac patients and elderly subjects. Br J Clin Pharmacol 4:439, 1977.PubMedGoogle Scholar
  35. 35.
    Drayer DE, et al: Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages. Clin Pharmacol Ther 34:14, 1983.PubMedCrossRefGoogle Scholar
  36. 36.
    Davis D, et al: The effects of age and smoking on the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol 18:261, 1985.Google Scholar
  37. 37.
    Cusack B, et al: Pharmacokinetics of lignocaine in the elderly. Br J Clin Pharmacol 9:293, 1979.Google Scholar
  38. 38.
    Antonelli D, et al: Sinus standstill following accidental lidocaine overdose. Am Heart J 107:1042, 1984.PubMedCrossRefGoogle Scholar
  39. 39.
    Cheng TO, Wadhwa K: Sinus standstill following intravenous lidocaine administration. JAMA 223:790, 1973.PubMedCrossRefGoogle Scholar
  40. 40.
    Badui E, Garcia-Rubi D, Estanol B: Inadvertent massive lidocaine overdose causing temporary complete heart block in myocardial infarction. Am Heart J 102:801, 1981.PubMedCrossRefGoogle Scholar
  41. 41.
    Kosowsky BD, Mufti SI, Grewal GS, Moon RHS, Cashin L, Pastore JO, Ramaswamy K: Effect of local lidocaine anesthesia on ventricular escape intervals during permanent pacemaker implantation in patients with complete heart block. Am J of Cardiol 51:101, 1983.CrossRefGoogle Scholar
  42. 42.
    Rothstein P, Dornbusch J, Shaywitz BA: Prolonged seizures associated with the use of viscous lidocaine. Pediatr 101:461, 1982.CrossRefGoogle Scholar
  43. 43.
    Laurikainen E, Kanto J: Saliva concentrations of lignocaine in patients with acute myocardial ischemia. Br J Clin Pharmacol 16:199, 1983.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1988

Authors and Affiliations

  • Adam Schneeweiss
    • 1
  • Gotthard Schettler
    • 2
  1. 1.Geriatric Cardiology Research FoundationTel-AvivIsrael
  2. 2.Department of MedicineUniversity of HeidelbergGermany

Personalised recommendations